|
IV Sotalol |
PO Sotalol |
p-value |
Bradycardia leading to drug discontinuation or dose reduction (n, %) |
7 (24.1%) |
2 (10.0%) |
0.209 |
QT prolongation leading to drug discontinuation or dose reduction (n,
%) |
3 (10.3%) |
6 (30.0%) |
0.081 |
VT/VF |
0 |
0 |
- |
Average Length of Stay (mean, range) |
1.0 (1 - 1) |
3.6 (3 - 6) |
< 0.001 |